• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人中的耐多药结核病

MDR tuberculosis in elderly.

作者信息

Bansal Avdhesh, Arora Shweta

机构信息

Indraprastha Apollo Hospitals, New Delhi, India.

Safdarjung Hospital, New Delhi, India.

出版信息

Indian J Tuberc. 2022;69 Suppl 2:S267-S271. doi: 10.1016/j.ijtb.2022.10.018. Epub 2022 Oct 30.

DOI:10.1016/j.ijtb.2022.10.018
PMID:36400522
Abstract

Tuberculosis is very common in young population, but it has emerged in a significant number in geriatric/elderly population (>60 Yrs. of age) as the population is ageing. Most cases of TB in the elderly are linked to the reactivation of lesions that have remained dormant. The awakening of these lesions is attributable to changes in the immune system related to senescence. Mortality rate from tuberculosis remains higher in elderly patients. Diagnosis is difficult as symptoms of active TB are nonspecific and less pronounced in the elderly. MDR TB is known to occur in poorly compliant patients (non-adherence) and this can be a major issue in elderly due to loss of independence and frailty resulting in treatment failure. Multidisciplinary management, involving geriatricians and infectious disease specialists is essential throughout care to optimize a favourable outcome in these vulnerable patients.

摘要

结核病在年轻人群中非常常见,但随着人口老龄化,在老年人群(>60岁)中也出现了大量病例。老年人中的大多数结核病病例与潜伏病变的重新激活有关。这些病变的激活归因于与衰老相关的免疫系统变化。老年患者的结核病死亡率仍然较高。由于活动性结核病的症状不具有特异性且在老年人中不太明显,因此诊断困难。耐多药结核病已知发生在依从性差的患者(不坚持治疗)中,由于独立性丧失和身体虚弱导致治疗失败,这在老年人中可能是一个主要问题。在整个护理过程中,由老年病专家和传染病专家参与的多学科管理对于优化这些脆弱患者的良好结局至关重要。

相似文献

1
MDR tuberculosis in elderly.老年人中的耐多药结核病
Indian J Tuberc. 2022;69 Suppl 2:S267-S271. doi: 10.1016/j.ijtb.2022.10.018. Epub 2022 Oct 30.
2
Tuberculosis in the Elderly.老年人结核病
J Clin Med. 2021 Dec 15;10(24):5888. doi: 10.3390/jcm10245888.
3
Opportunistic infections in elderly TB patients.老年肺结核患者的机会性感染。
Indian J Tuberc. 2022;69 Suppl 2:S259-S263. doi: 10.1016/j.ijtb.2022.10.015. Epub 2022 Oct 27.
4
Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.乌干达耐多药结核病患者死亡风险因素的病例对照研究。
BMC Infect Dis. 2021 Mar 22;21(1):292. doi: 10.1186/s12879-021-05967-2.
5
Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India.印度南部结核病控制项目下老年结核病患者的概况及抗结核治疗反应
PLoS One. 2014 Mar 11;9(3):e88045. doi: 10.1371/journal.pone.0088045. eCollection 2014.
6
Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.近年来耐多药结核病的诊断和治疗进展。
Respir Med. 2009 Dec;103(12):1777-90. doi: 10.1016/j.rmed.2009.07.010. Epub 2009 Aug 5.
7
Challenges of diabetes in elderly TB patients.老年结核病患者的糖尿病挑战。
Indian J Tuberc. 2022;69 Suppl 2:S264-S266. doi: 10.1016/j.ijtb.2022.10.017. Epub 2022 Oct 28.
8
Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.吡嗪酰胺在我国制定耐多药结核分枝杆菌新治疗方案中的价值。
BMC Infect Dis. 2020 Jan 7;20(1):19. doi: 10.1186/s12879-020-4758-9.
9
Risk Factors for Multidrug-resistant Tuberculosis.耐多药结核病的危险因素
Acta Med Indones. 2018 Jan;50(1):1-2.
10
[Management of multidrug-resistant tuberculosis].[耐多药结核病的管理]
Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. doi: 10.1016/j.pneumo.2014.05.001. Epub 2014 Aug 19.

引用本文的文献

1
Comprehensive analysis of tuberculosis burden trends and attributable risk factors in the BRICS countries from 1990 to 2021, with forecasts for the next 15 years.对1990年至2021年金砖国家结核病负担趋势及归因风险因素进行综合分析,并对未来15年进行预测。
Int J Surg. 2025 Sep 1;111(9):6050-6062. doi: 10.1097/JS9.0000000000002720. Epub 2025 Jun 20.
2
Assessing the Role of Polyamine Metabolites in Blood and the DNA Methylation of in Patients with Multidrug-Resistant Tuberculosis.评估多胺代谢产物在耐多药结核病患者血液中的作用及其DNA甲基化情况
Int J Med Sci. 2025 Mar 10;22(8):1762-1772. doi: 10.7150/ijms.102568. eCollection 2025.
3
Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019.
全球 1990 年至 2019 年耐多药结核病的流行和负担。
BMC Infect Dis. 2024 Feb 22;24(1):243. doi: 10.1186/s12879-024-09079-5.
4
Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients.老年及高龄结核病患者有效抗结核治疗方案及不良结局相关危险因素的评估
Infect Drug Resist. 2023 Jun 19;16:3903-3915. doi: 10.2147/IDR.S414918. eCollection 2023.